speb/financial-data huggingface dataset:
Financial ratios for KNE.V — annual report dated 2024-12-31
Total revenue: 1455160.13986014
Gross profit: 609857.3426573427
Operating income: -2743354.5454545454
Net income: 4312067.832167832
Capital expenditures: 17301.398601398603
Operating cash flow: -2875067.132867133
Depreciation & amortization: 152776.22377622378
Net tangible assets: -1514190.2097902098
Owner earnings: 4447542.657342657
Return on net tangible assets (%): -293.72417207471324
Buffett classification: The Gruesome
Stock price: 0.07692307692307693
P/E ratio: 3.6580087644741375
Shares outstanding: 205056565
Book value: -1139326.5734265738
Market cap (USD): 15773581.923076924
Debt to equity: -1.3350875287020854
Current ratio: 0.4269186481961357
Quick ratio: 0.27088567676294056
Interest coverage ratio: -7.191825548141086
COGS to revenue (%): 58.090018689217395
R&D to revenue (%): 82.5124382532574
SG&A to revenue (%): 147.92349771418714
Free cash flow (dilution-adjusted): -3435185.314685315
Buyback yield (%): 0
Retained earnings: -24066521.67832168
Inventory turnover: 3.21455772616306
Receivables turnover: 23.62380227964216
Capitalized R&D asset: 1987009.6513266147
ROCI (R&D-adjusted, %): -120.3851964623035
Rosenberg metric: 0.6599693446320262
FCF margin (%): -236.06922843663662
Revenue growth (%): 1189.3082189658912
Rule of 40 score: 953.2389905292546
Financial ratios for KNE.V — quarterly report dated 2025-03-31
Total revenue: 288470.6293706294
Gross profit: 29683.216783216783
Operating income: -811928.6713286714
Net income: -852095.8041958043
Capital expenditures: 9618.88111888112
Operating cash flow: -771807.6923076924
Depreciation & amortization: 33462.93706293707
Net tangible assets: -1183590.2097902098
Owner earnings: -828251.7482517484
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 205056565
Book value: -793020.2797202799
Market cap (USD): 14339619.93006993
Debt to equity: -1.833459580483219
Current ratio: 0.5629576054929394
Quick ratio: 0.4353811602473857
Interest coverage ratio: -19.79334799434017
COGS to revenue (%): 89.71014246823736
R&D to revenue (%): 63.27533920143124
SG&A to revenue (%): 228.47425414471786
Free cash flow (dilution-adjusted): -904251.7482517483
Buyback yield (%): 0
Retained earnings: -24918617.482517485
Inventory turnover: 1.2608077951723082
Receivables turnover: 2.022310901505532
Capitalized R&D asset: 467173.47552447557
ROCI (R&D-adjusted, %): -105.90356470257389
Rosenberg metric: 0.213411552851671
FCF margin (%): -313.4640605265774
Revenue growth (%): 227.7606508922754
Rule of 40 score: -85.70340963430198
Financial ratios for KNE.V — quarterly report dated 2025-06-30
Total revenue: 20435.76642335766
Gross profit: -33230.656934306564
Operating income: -201062.77372262772
Net income: -254409.48905109486
Capital expenditures: 6467.153284671533
Operating cash flow: -564162.7737226277
Depreciation & amortization: 33813.868613138686
Net tangible assets: -587540.1459854015
Owner earnings: -227062.77372262772
Buffett classification: The Gruesome
Stock price: 0.0364963503649635
Shares outstanding: 205056565
Book value: -171523.35766423354
Market cap (USD): 7483816.240875912
Debt to equity: -11.090030512326216
Current ratio: 1.2030805321698208
Quick ratio: 1.0344461705810537
Interest coverage ratio: -2.629400534555174
COGS to revenue (%): 262.6102796728221
R&D to revenue (%): 322.2738150516127
SG&A to revenue (%): 498.99274922313106
Free cash flow (dilution-adjusted): -426156.93430656934
Buyback yield (%): 0
Retained earnings: -26264353.28467153
Inventory turnover: 0.21976685099387236
Receivables turnover: 0.2012970672188549
Capitalized R&D asset: 328351.89331836044
ROCI (R&D-adjusted, %): -21.635003421273602
Rosenberg metric: -0.34467544284538054
FCF margin (%): -2085.348430188949
Revenue growth (%): -92.9158242321087
Rule of 40 score: -2178.2642544210576
Financial ratios for KNE.V — quarterly report dated 2025-09-30
Total revenue: 6114.3884892086335
Gross profit: -3689.2086330935253
Operating income: -390959.71223021584
Net income: -436938.84892086335
Capital expenditures: 43165.467625899284
Operating cash flow: -502313.6690647482
Depreciation & amortization: 26057.553956834534
Net tangible assets: -979416.54676259
Owner earnings: -454046.7625899281
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 205056565
Book value: -570769.0647482015
Market cap (USD): 7376135.431654678
Debt to equity: -2.8957080501002683
Current ratio: 0.8996357612686358
Quick ratio: 0.7171951034431538
Interest coverage ratio: -7.5619781810085716
COGS to revenue (%): 160.33651017766798
R&D to revenue (%): 1878.3150958936346
SG&A to revenue (%): 4455.441816684315
Free cash flow (dilution-adjusted): -523590.64748201444
Buyback yield (%): 0
Retained earnings: -26323387.769784175
Inventory turnover: 0.04019799585247067
Receivables turnover: 0.06480168351708679
Capitalized R&D asset: 219208.24899922847
ROCI (R&D-adjusted, %): -46.506021328026776
Rosenberg metric: 0.448555135077769
FCF margin (%): -8563.254500529474
Revenue growth (%): -70.07996488832437
Rule of 40 score: -8633.334465417798
Financial ratios for KNE.V — quarterly report dated 2025-12-31
Total revenue: -15430.656934306568
Gross profit: 5523.3576642335765
Operating income: -491897.8102189781
Net income: -399164.96350364963
Capital expenditures: 0
Operating cash flow: -496797.8102189781
Depreciation & amortization: 23606.56934306569
Net tangible assets: -959740.8759124087
Owner earnings: -375558.39416058396
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 205056565
Book value: -544923.3576642335
Market cap (USD): 5987052.9927007295
Debt to equity: -3.086629741006905
Current ratio: 0.6751956135245929
Quick ratio: 0.47352182685605027
Interest coverage ratio: -66.45301252341979
Free cash flow (dilution-adjusted): -503459.1240875912
Buyback yield (%): 0
Retained earnings: -27106835.766423356
Inventory turnover: -0.05689489101438475
Receivables turnover: -0.5792574325250034
Capitalized R&D asset: 214987.1633146038
ROCI (R&D-adjusted, %): -123.44692201129268
Rosenberg metric: 0.08021565763342482
Revenue growth (%): -352.36631531575625
Rule of 40 score: -352.36631531575625
Financial ratios for KNE.V — annual report dated 2025-12-31
Total revenue: 312313.13868613134
Gross profit: -467.1532846715328
Operating income: -1937115.3284671532
Net income: -1986305.8394160583
Capital expenditures: 40222.62773722628
Operating cash flow: -2376217.518248175
Depreciation & amortization: 118786.8613138686
Net tangible assets: -959740.8759124087
Owner earnings: -1907741.605839416
Buffett classification: The Gruesome
Stock price: 0.029197080291970802
Shares outstanding: 205056565
Book value: -544923.3576642335
Market cap (USD): 5987052.9927007295
Debt to equity: -3.086629741006905
Current ratio: 0.6751956135245929
Quick ratio: 0.47352182685605027
Interest coverage ratio: -10.932027236889262
COGS to revenue (%): 100.14957849248252
R&D to revenue (%): 156.64210307360432
SG&A to revenue (%): 463.45610455536627
Free cash flow (dilution-adjusted): -2398237.2262773723
Buyback yield (%): 0
Retained earnings: -27106835.766423356
Inventory turnover: 0.8492692672060123
Receivables turnover: 11.724044389642417
Capitalized R&D asset: 1557149.9035781738
ROCI (R&D-adjusted, %): -131.8960355077245
Rosenberg metric: -0.5083122668569307
FCF margin (%): -767.8950800361794
Revenue growth (%): -78.53754166767179
Rule of 40 score: -846.4326217038512
Financial ratios for KNRCON.NS — annual report dated 2022-03-31
Total revenue: 436414321.5086377
Gross profit: 113170605.30133192
Operating income: 85250468.15244627
Net income: 50355360.67519452
Capital expenditures: 46629961.75656073
Operating cash flow: -44368086.50929711
Depreciation & amortization: 21748727.41658974
Net tangible assets: 263145654.75405514
Owner earnings: 25474126.335223526
Return on net tangible assets (%): 9.680618271668786
Capex to operating income (%): 54.69760198052669
Buffett classification: The Good
Stock price: 3.7324277990241326
P/E ratio: 20.845602633217116
Shares outstanding: 281234600
Book value: 337485388.3687195
P/B ratio: 3.1103208472557524
Market cap (USD): 1049687839.0874323
Debt to equity: 0.571884308382344
Current ratio: 1.5093227962689713
Quick ratio: 1.3283168295711083
Effective tax rate (%): 34.96545326810344
Interest coverage ratio: 4.595694599659334
COGS to revenue (%): 74.06808170040956
SG&A to revenue (%): 0.652727328657301
Free cash flow (dilution-adjusted): -91487181.85414743
Buyback yield (%): 0
Retained earnings: 282047303.1781617
Inventory turnover: 10.77881796794266
Receivables turnover: 3.859107068995334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.10505503285788
FCF margin (%): -20.963377539464336
Rule of 40 score: -20.963377539464336
Financial ratios for KNRCON.NS — annual report dated 2023-03-31
Total revenue: 460151485.9926919
Gross profit: 111065688.18514009
Operating income: 90272095.00609013
Net income: 55787356.881851405
Capital expenditures: 11430024.360535933
Operating cash flow: 145448830.6942753
Depreciation & amortization: 22009853.83678441
Net tangible assets: 301630316.68696713
Owner earnings: 66367186.35809988
Return on net tangible assets (%): 22.00282355137927
Capex to operating income (%): 12.66174708780694
Buffett classification: The Great
Stock price: 3.081120584652863
P/E ratio: 15.532510654909828
Shares outstanding: 281234600
Book value: 334692825.8221681
P/B ratio: 2.5889939918730724
Market cap (USD): 866517715.176614
Debt to equity: 0.2373004701422189
Current ratio: 2.022397487686833
Quick ratio: 1.8030093732180283
Effective tax rate (%): 35.49925357469464
Interest coverage ratio: 5.208619164114951
COGS to revenue (%): 75.86323383362843
SG&A to revenue (%): 0.7592108694173875
Free cash flow (dilution-adjusted): 126719147.3812424
Buyback yield (%): 0
Retained earnings: 315438246.04141295
Inventory turnover: 12.23596938013124
Receivables turnover: 6.064957288283616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.634394080767407
FCF margin (%): 27.53857180486318
Revenue growth (%): 5.439135086584076
Rule of 40 score: 32.977706891447255
Financial ratios for KNRCON.NS — annual report dated 2024-03-31
Total revenue: 487326346.08466244
Gross profit: 116781100.85142103
Operating income: 109336191.3898549
Net income: 93224463.36491185
Capital expenditures: 9272274.853099892
Operating cash flow: -35630519.2469121
Depreciation & amortization: 18806967.262261663
Net tangible assets: 394877311.4282288
Owner earnings: 102759155.77407362
Return on net tangible assets (%): 26.023059011014027
Capex to operating income (%): 8.480517507728232
Buffett classification: The Great
Stock price: 2.9487763915547025
P/E ratio: 8.895711694495676
Shares outstanding: 281234600
Book value: 419435651.7568053
P/B ratio: 1.9771756299084675
Market cap (USD): 829297948.9683301
Debt to equity: 0.3609361924792361
Current ratio: 2.2589918948141188
Quick ratio: 2.0585096282666364
Effective tax rate (%): 20.682316237734728
Interest coverage ratio: 9.143384203759826
COGS to revenue (%): 76.03636622774897
SG&A to revenue (%): 1.0558626890046945
Free cash flow (dilution-adjusted): -45567166.32689771
Buyback yield (%): 0
Retained earnings: 402939908.8619739
Inventory turnover: 13.989758876319643
Receivables turnover: 6.029542248709502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.390479063373135
FCF margin (%): -9.350441791829864
Revenue growth (%): 5.905633453154198
Rule of 40 score: -3.4448083386756663
Financial ratios for KNRCON.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 497063580.98423314
Buffett classification: The Gruesome
Stock price: 4.1006927854753945
Shares outstanding: 281234600
Book value: 504059651.2183469
P/B ratio: 2.2879369385320913
Market cap (USD): 1153256695.2460585
Debt to equity: 0.33259900254678487
Current ratio: 2.78323015511972
Quick ratio: 2.6185552487190824
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KNRCON.NS — quarterly report dated 2024-12-31
Total revenue: 98857582.4688192
Gross profit: 44175113.649609506
Operating income: 27068819.2096981
Net income: 28975987.877374984
Capital expenditures: 0
Depreciation & amortization: 2723475.929595524
Owner earnings: 31699463.806970507
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.02972374402611
P/E ratio: 9.777904294909185
Shares outstanding: 281234600
Market cap (USD): 1133297745.2616854
Effective tax rate (%): 19.967746870746975
Interest coverage ratio: 5.604793280718268
COGS to revenue (%): 55.31439010908158
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KNRCON.NS — quarterly report dated 2025-03-31
Total revenue: 114006312.83610006
Gross profit: 41490191.723170444
Operating income: 23221849.427168574
Net income: 16277320.551788636
Capital expenditures: 0
Depreciation & amortization: 2672059.855038578
Net tangible assets: 530878653.26163197
Owner earnings: 18949380.406827215
Return on net tangible assets (%): 3.569437250943376
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.658886684560626
P/E ratio: 11.484859114228799
Shares outstanding: 281234600
Book value: 530883621.6974514
P/B ratio: 1.4085402197694576
Market cap (USD): 747770933.1777338
Debt to equity: 0.4072675848350819
Current ratio: 4.078391545886103
Quick ratio: 3.871937317445619
Effective tax rate (%): 87.31324671005913
Interest coverage ratio: 4.894496147525029
COGS to revenue (%): 63.607110263430435
Buyback yield (%): 0
Retained earnings: 509113759.64461064
Inventory turnover: 3.8668923745962003
Receivables turnover: 1.058725898545309
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.126034967548847
Revenue growth (%): 15.323792054149147
Rule of 40 score: 15.323792054149147
Financial ratios for KNRCON.NS — annual report dated 2025-03-31
Total revenue: 555665817.1615618
Gross profit: 256441372.4573299
Operating income: 153279927.5192892
Net income: 117123462.70750526
Capital expenditures: 2987210.6616787463
Operating cash flow: -66235796.11877484
Depreciation & amortization: 36733633.38788871
Net tangible assets: 530878653.26163197
Owner earnings: 150869885.43371522
Return on net tangible assets (%): 28.418902230631282
Capex to operating income (%): 1.9488596517654455
Buffett classification: The Great
Stock price: 2.658886684560626
P/E ratio: 6.384467431988046
Shares outstanding: 281234600
Book value: 530883621.6974514
P/B ratio: 1.4085402197694576
Market cap (USD): 747770933.1777338
Debt to equity: 0.4072675848350819
Current ratio: 4.078391545886103
Quick ratio: 3.871937317445619
Effective tax rate (%): 20.159854847236478
Interest coverage ratio: 6.3067964816990045
COGS to revenue (%): 53.84971244636259
SG&A to revenue (%): 0.7758156280444184
Free cash flow (dilution-adjusted): -69506242.69347674
Buyback yield (%): 0.13288657258676106
Retained earnings: 509113759.64461064
Inventory turnover: 15.956020616680112
Receivables turnover: 5.1602211924093
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.633947126022438
FCF margin (%): -12.508641083687094
Revenue growth (%): 14.023348342637505
Rule of 40 score: 1.514707258950411
Financial ratios for KNRCON.NS — quarterly report dated 2025-06-30
Total revenue: 71697027.84928623
Gross profit: 33564989.46875732
Operating income: 19634191.43458928
Net income: 14440381.465012873
Capital expenditures: 0
Depreciation & amortization: 1804224.1984554178
Owner earnings: 16244605.66346829
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6030891645214136
P/E ratio: 12.263921718465136
Shares outstanding: 281234600
Market cap (USD): 732078739.948514
Effective tax rate (%): 16.100701481551745
Interest coverage ratio: 3.4703776398491835
COGS to revenue (%): 53.18496390211037
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -37.111352813979096
Rule of 40 score: -37.111352813979096
Financial ratios for KNRCON.NS — quarterly report dated 2025-09-30
Total revenue: 72886674.18263811
Gross profit: 34217113.866967306
Operating income: 20008523.111612175
Net income: 11799244.644870348
Capital expenditures: 0
Depreciation & amortization: 1700845.5467869223
Net tangible assets: 536924599.7745209
Owner earnings: 13500090.191657271
Return on net tangible assets (%): 2.5143363141354627
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2359639233370916
P/E ratio: 8.79570021357416
Shares outstanding: 281234600
Book value: 536926595.2649379
P/B ratio: 1.1711664595117537
Market cap (USD): 628830419.5941377
Debt to equity: 0.4872651223909164
Current ratio: 4.38028290681919
Quick ratio: 4.172106921537581
Effective tax rate (%): 22.21429781518299
Interest coverage ratio: 3.365685015806671
COGS to revenue (%): 53.05436247341086
Buyback yield (%): 0
Inventory turnover: 2.1630694233795063
Receivables turnover: 0.7393139057795164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.560259519924436
Revenue growth (%): 1.6592686880307324
Rule of 40 score: 1.6592686880307324
Financial ratios for KNRCON.NS — quarterly report dated 2025-12-31
Total revenue: 82788804.72318147
Gross profit: 30424562.77152724
Operating income: 16898551.854739893
Net income: 11451743.344101593
Capital expenditures: 0
Depreciation & amortization: 1672006.2381641974
Owner earnings: 13123749.58226579
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8133006572351567
P/E ratio: 9.449235935923435
Shares outstanding: 281234600
Market cap (USD): 509962885.0172664
Effective tax rate (%): 7.79026203658077
Interest coverage ratio: 2.7657390914344995
COGS to revenue (%): 63.250390106178045
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.58565286671029
Rule of 40 score: 13.58565286671029
Financial ratios for KREBSBIO.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8864565475405515
Shares outstanding: 21560586
Market cap (USD): 40673108.628511146
Buyback yield (%): 0
Retained earnings: -29818805.22220757
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KREBSBIO.NS — annual report dated 2023-03-31
Total revenue: 6350109.622411693
Gross profit: 1191546.8940316688
Operating income: -2672241.169305725
Net income: -3007539.5858708895
Capital expenditures: 1324043.8489646774
Operating cash flow: -3010133.982947625
Depreciation & amortization: 798842.8745432401
Net tangible assets: -12442058.465286236
Owner earnings: -3532740.560292327
Buffett classification: The Gruesome
Stock price: 0.6881851400730816
Shares outstanding: 21560586
Book value: -12114774.665042631
Market cap (USD): 14837674.896467723
Debt to equity: -2.2960498600977455
Current ratio: 0.32707459774726244
Quick ratio: 0.08380664172675935
Interest coverage ratio: -7.384416021541568
COGS to revenue (%): 81.23580591701447
SG&A to revenue (%): 1.6491989933709796
Free cash flow (dilution-adjusted): -4334177.831912302
Buyback yield (%): 0
Retained earnings: -30509756.394640684
Inventory turnover: 3.5453890972408253
Receivables turnover: 99.26580350342726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.42899814898671
FCF margin (%): -68.25359071937147
Rule of 40 score: -68.25359071937147
Financial ratios for KREBSBIO.NS — annual report dated 2024-03-31
Total revenue: 6046468.401486989
Gross profit: 2311152.4163568774
Operating income: -1822244.8734860294
Net income: -2365799.256505576
Capital expenditures: 878678.4986209378
Operating cash flow: 283595.1552943998
Depreciation & amortization: 811416.236958868
Net tangible assets: -14596462.405564217
Owner earnings: -2433061.5181676457
Buffett classification: The Gruesome
Stock price: 0.7371641074856047
Shares outstanding: 21560586
Book value: -14296282.527881037
Market cap (USD): 15893690.135556623
Debt to equity: -2.0020349498014967
Current ratio: 0.2820815119214541
Quick ratio: 0.1236506188352991
Interest coverage ratio: -3.2428562282592455
COGS to revenue (%): 61.7768213956348
SG&A to revenue (%): 1.1901668930912408
Free cash flow (dilution-adjusted): -845437.1027701163
Buyback yield (%): 0
Retained earnings: -32406703.44165967
Inventory turnover: 3.1796170021640604
Receivables turnover: 26.49022801302932
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.061367980966265
FCF margin (%): -13.982328966809792
Revenue growth (%): -4.7816689628955595
Rule of 40 score: -18.76399792970535
Financial ratios for KREBSBIO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -15833707.596751075
Buffett classification: The Gruesome
Stock price: 0.959866220735786
Shares outstanding: 21560586
Book value: -15545723.841376018
Market cap (USD): 20695278.200668897
Debt to equity: -1.5718024292194777
Current ratio: 0.2526901108055677
Quick ratio: 0.1781894686500851
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KREBSBIO.NS — annual report dated 2025-03-31
Total revenue: 5063350.479307925
Gross profit: 4413864.858545709
Operating income: -2539034.3698854335
Net income: -3149321.9546411033
Capital expenditures: 397439.79424830485
Operating cash flow: -922492.4012158054
Depreciation & amortization: 781996.7266775777
Net tangible assets: -17367091.419219077
Owner earnings: -2764765.0222118306
Buffett classification: The Gruesome
Stock price: 0.7745361185669274
Shares outstanding: 21560586
Book value: -17095955.10872107
Market cap (USD): 16699452.594468435
Debt to equity: -1.7588246074229268
Current ratio: 0.0990967495153396
Quick ratio: 0.04083607901775495
Interest coverage ratio: -3.672330999966183
COGS to revenue (%): 12.827190679697727
SG&A to revenue (%): 2.170766001953274
Free cash flow (dilution-adjusted): -1339046.060322656
Buyback yield (%): 0
Retained earnings: -34751180.734159455
Inventory turnover: 0.921114150708779
Receivables turnover: 866.2379999999999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.15381738526474
FCF margin (%): -26.445849754917244
Revenue growth (%): -16.259374181750267
Rule of 40 score: -42.70522393666751
Financial ratios for KREBSBIO.NS — quarterly report dated 2025-03-31
Total revenue: 713116.6705634791
Gross profit: 646831.8915127425
Operating income: -815653.4954407294
Net income: -966612.1112929623
Capital expenditures: 0
Depreciation & amortization: 183422.96001870467
Net tangible assets: -17367091.419219077
Owner earnings: -783189.1512742577
Buffett classification: The Gruesome
Stock price: 0.7745361185669274
Shares outstanding: 21560586
Book value: -17095955.10872107
Market cap (USD): 16699452.594468435
Debt to equity: -1.7588246074229268
Current ratio: 0.0990967495153396
Quick ratio: 0.04083607901775495
Interest coverage ratio: -4.320988418901344
COGS to revenue (%): 9.295081967213115
Buyback yield (%): 0
Retained earnings: -34751180.734159455
Inventory turnover: 0.0940064660532206
Receivables turnover: 122.00000000000001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.650516337325124
Rule of 40 score: 0
Financial ratios for KREBSBIO.NS — quarterly report dated 2025-06-30
Total revenue: 641340.9782354318
Gross profit: 607500.5850690382
Operating income: -431301.19354083785
Net income: -623016.6159606834
Capital expenditures: 0
Depreciation & amortization: 187069.97425696233
Owner earnings: -435946.64170372114
Buffett classification: The Gruesome
Stock price: 1.0273812309852564
Shares outstanding: 21560586
Market cap (USD): 22150941.385443483
Interest coverage ratio: -2.2337434094903337
COGS to revenue (%): 5.276505683373169
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -10.065070035641249
Rule of 40 score: -10.065070035641249
Financial ratios for KREBSBIO.NS — quarterly report dated 2025-09-30
Total revenue: 469830.89064261556
Gross profit: 469650.50732807216
Operating income: -497925.59188275086
Net income: -692536.6403607666
Capital expenditures: 0
Depreciation & amortization: 183122.88613303268
Net tangible assets: -18030800.450958285
Owner earnings: -509413.7542277339
Buffett classification: The Gruesome
Stock price: 0.7962795941375422
Shares outstanding: 21560586
Book value: -17779718.151071027
Market cap (USD): 17168254.669447575
Debt to equity: -1.3914204967341148
Current ratio: 0.09118115769264552
Quick ratio: 0.03943077990359433
Interest coverage ratio: -2.548675630446073
COGS to revenue (%): 0.03839324278926909
Buyback yield (%): 0
Inventory turnover: 0.0002771138591568811
Receivables turnover: 29.451590106007068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.822376822272327
Revenue growth (%): -26.74241837231491
Rule of 40 score: -26.74241837231491
Financial ratios for KREBSBIO.NS — quarterly report dated 2025-12-31
Total revenue: 810315.2500835469
Gross profit: 810125.8772418402
Operating income: -149025.2868441573
Net income: -348278.9350562549
Capital expenditures: 0
Depreciation & amortization: 182087.557090342
Net tangible assets: -18158984.070402138
Owner earnings: -166191.37796591292
Buffett classification: The Gruesome
Stock price: 0.7690765289072075
Shares outstanding: 21560586
Book value: -17916063.27280829
Market cap (USD): 16581740.642085332
Debt to equity: -1.3770376012310943
Current ratio: 0.08759284312759268
Quick ratio: 0.035928610466522716
Interest coverage ratio: -0.7461654303084387
COGS to revenue (%): 0.023370267520827034
Buyback yield (%): 0
Inventory turnover: 0.00029481132075471697
Receivables turnover: 145.48399999999998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.46367470212335
Revenue growth (%): 72.46955579596536
Rule of 40 score: 72.46955579596536
Financial ratios for LLYVK — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -11000000
Net income: -142000000
Capital expenditures: 0
Operating cash flow: -13000000
Depreciation & amortization: 0
Net tangible assets: -188000000
Owner earnings: -142000000
Buffett classification: The Gruesome
Stock price: 37.39
Shares outstanding: 63899793
Book value: -165000000
Market cap (USD): 2389213260.27
Debt to equity: -7.9818181818181815
Current ratio: 3.8125
Quick ratio: 3.8125
Interest coverage ratio: -1.1
Free cash flow (dilution-adjusted): -15000000
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0166358595194085
Rule of 40 score: 0
Financial ratios for LLYVK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.33
Shares outstanding: 63899793
Market cap (USD): 3279976374.69
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LLYVK — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -4000000
Net income: -107000000
Capital expenditures: 0
Operating cash flow: -3000000
Depreciation & amortization: 0
Net tangible assets: -466512000
Owner earnings: -107000000
Buffett classification: The Gruesome
Stock price: 68.06
Shares outstanding: 63899793
Book value: -177122000
Market cap (USD): 4349019911.58
Debt to equity: -8.787158004087578
Current ratio: 2.519352103211217
Quick ratio: 2.519352103211217
Interest coverage ratio: -0.5714285714285714
Free cash flow (dilution-adjusted): -4000000
Buyback yield (%): 0
Retained earnings: -456109000
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.28621987267508964
Rule of 40 score: 0
Financial ratios for LLYVK — annual report dated 2024-12-31
Total revenue: 340493000
Gross profit: 47258000
Operating income: -49208000
Net income: -112764000
Capital expenditures: 0
Operating cash flow: -25228000
Depreciation & amortization: 27447000
Net tangible assets: -466512000
Owner earnings: -85317000
Buffett classification: The Gruesome
Stock price: 68.06
Shares outstanding: 63899793
Book value: -177122000
Market cap (USD): 4349019911.58
Debt to equity: -8.787158004087578
Current ratio: 2.519352103211217
Quick ratio: 2.519352103211217
Interest coverage ratio: -1.6897771367741492
COGS to revenue (%): 86.12071320115244
SG&A to revenue (%): 20.27031392715856
Free cash flow (dilution-adjusted): -36235000
Buyback yield (%): 0
Retained earnings: -456109000
Receivables turnover: 16.977960608327102
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.5210768736489526
FCF margin (%): -10.641922154053093
Rule of 40 score: -10.641922154053093
Financial ratios for LLYVK — quarterly report dated 2025-03-31
Total revenue: 47059000
Gross profit: 5510000
Operating income: -17282000
Net income: -29476000
Capital expenditures: 27000000
Operating cash flow: -16458000
Depreciation & amortization: 7191000
Net tangible assets: -374000000
Owner earnings: -49285000
Buffett classification: The Gruesome
Stock price: 68.14
Shares outstanding: 63899793
Book value: -352000000
Market cap (USD): 4354131895.02
Debt to equity: -4.494318181818182
Interest coverage ratio: -2.356422143441505
COGS to revenue (%): 88.29129390764786
SG&A to revenue (%): 34.56937036486113
Free cash flow (dilution-adjusted): -16919000
Buyback yield (%): 0
Receivables turnover: 47.059
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4038992688870837
FCF margin (%): -35.952740177224335
Rule of 40 score: -35.952740177224335
Financial ratios for LLYVK — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -7000000
Net income: -178000000
Capital expenditures: 0
Operating cash flow: 458000
Depreciation & amortization: 0
Net tangible assets: -511000000
Owner earnings: -178000000
Buffett classification: The Gruesome
Stock price: 81.16
Shares outstanding: 63899793
Book value: -489000000
Market cap (USD): 5186107199.88
Debt to equity: -3.61758691206544
Current ratio: 0.17457627118644067
Quick ratio: 0.17457627118644067
Interest coverage ratio: -0.875
Free cash flow (dilution-adjusted): -1081000
Buyback yield (%): 0
Receivables turnover: 0
Capitalized R&D asset: 0
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for LLYVK — quarterly report dated 2025-12-31
Total revenue: 381951000
Gross profit: 73522000
Operating income: -31732000
Net income: 161033000
Capital expenditures: 0
Operating cash flow: -1455000
Depreciation & amortization: 26120000
Net tangible assets: -295053000
Owner earnings: 187153000
Return on net tangible assets (%): -63.43029896323711
Buffett classification: The Gruesome
Stock price: 83.16
P/E ratio: 8.249717116802145
Shares outstanding: 63899793
Book value: -27135000
Market cap (USD): 5313906785.88
Debt to equity: -61.41684171733923
Current ratio: 0.3318695791315644
Quick ratio: 0.3318695791315644
Effective tax rate (%): 25.099523683144533
Interest coverage ratio: -4.213517461160537
COGS to revenue (%): 80.75093402033245
SG&A to revenue (%): 20.71836439752743
Free cash flow (dilution-adjusted): -3984000
Buyback yield (%): 0
Retained earnings: -453647000
Receivables turnover: 12.57576056894508
Capitalized R&D asset: 0
FCF margin (%): -1.043065733562682
Rule of 40 score: -1.043065733562682
Financial ratios for LLYVK — annual report dated 2025-12-31
Total revenue: 381951000
Gross profit: 73522000
Operating income: -51732000
Net income: -86967000
Capital expenditures: 0
Operating cash flow: -29455000
Depreciation & amortization: 26120000
Net tangible assets: -295053000
Owner earnings: -60847000
Buffett classification: The Gruesome
Stock price: 83.16
Shares outstanding: 63899793
Book value: -27135000
Market cap (USD): 5313906785.88
Debt to equity: -61.41684171733923
Current ratio: 0.3318695791315644
Quick ratio: 0.3318695791315644
Interest coverage ratio: -1.7517862585080086
COGS to revenue (%): 80.75093402033245
SG&A to revenue (%): 25.954638160392303
Free cash flow (dilution-adjusted): -34984000
Buyback yield (%): 0
Retained earnings: -453647000
Receivables turnover: 12.57576056894508
Capitalized R&D asset: 0
FCF margin (%): -9.159290066003232
Revenue growth (%): 12.17587439389356
Rule of 40 score: 3.016584327890328
Financial ratios for M7U.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.72727272727273
Shares outstanding: 6568820
Market cap (USD): 313511863.6363636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for M7U.DE — annual report dated 2022-12-31
Total revenue: 124247872.34042554
Gross profit: 73080851.0638298
Operating income: 15817021.276595745
Net income: 10584042.55319149
Capital expenditures: 1386170.2127659575
Operating cash flow: 10294680.85106383
Depreciation & amortization: 4356382.978723405
Net tangible assets: 25248936.170212768
Owner earnings: 13554255.319148937
Return on net tangible assets (%): 53.68248082919019
Capex to operating income (%): 8.763788001076136
Buffett classification: The Great
Stock price: 36.11702127659575
P/E ratio: 22.41546276007639
Shares outstanding: 6568820
Book value: 81943617.02127661
P/B ratio: 2.8952372414867513
Market cap (USD): 237246211.7021277
Debt to equity: 0.4095706700247964
Current ratio: 1.9766500536938625
Quick ratio: 1.3506622243026682
Effective tax rate (%): 30.62064156206416
Interest coverage ratio: 20.037735849056606
COGS to revenue (%): 41.1814064199053
SG&A to revenue (%): 4.101273192742715
Free cash flow (dilution-adjusted): 7558510.638297873
Buyback yield (%): 0
Retained earnings: 44121276.595744684
Inventory turnover: 2.1156417700360692
Receivables turnover: 7.110684931506849
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.558201472661755
FCF margin (%): 6.083412533285385
Rule of 40 score: 6.083412533285385
Financial ratios for M7U.DE — annual report dated 2023-12-31
Total revenue: 131094444.44444445
Gross profit: 83732222.22222222
Operating income: 16786666.666666668
Net income: 11702222.222222222
Capital expenditures: 2614444.4444444445
Operating cash flow: 3517777.7777777775
Depreciation & amortization: 5314444.444444444
Net tangible assets: 56240000
Owner earnings: 14402222.22222222
Return on net tangible assets (%): 25.608503240082182
Capex to operating income (%): 15.574530050304475
Buffett classification: The Great
Stock price: 35.333333333333336
P/E ratio: 19.833695024686673
Shares outstanding: 6568820
Book value: 115482222.22222221
P/B ratio: 2.009818500202052
Market cap (USD): 232098306.6666667
Debt to equity: 0.23910366193930765
Current ratio: 2.595108146351324
Quick ratio: 1.6763021359746648
Effective tax rate (%): 27.66483516483516
Interest coverage ratio: 14.027855153203342
COGS to revenue (%): 36.128321396787726
SG&A to revenue (%): 5.376954697631055
Free cash flow (dilution-adjusted): -6165555.555555555
Buyback yield (%): 0
Retained earnings: 56420000
Inventory turnover: 1.5629950132003523
Receivables turnover: 5.359543926592169
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.400886481162276
FCF margin (%): -4.703140229690214
Revenue growth (%): 5.510413961262898
Rule of 40 score: 0.8072737315726846
Financial ratios for M7U.DE — annual report dated 2024-12-31
Total revenue: 106682291.66666667
Gross profit: 69923958.33333334
Operating income: 7117708.333333334
Net income: -281250
Capital expenditures: 2394791.666666667
Operating cash flow: 8121875
Depreciation & amortization: 5332291.666666667
Net tangible assets: 51992708.333333336
Owner earnings: 2656250
Capex to operating income (%): 33.64554368505781
Buffett classification: The Good
Stock price: 18.333333333333336
Shares outstanding: 6568820
Book value: 107267708.33333334
P/B ratio: 1.1226898433630812
Market cap (USD): 120428366.66666669
Debt to equity: 0.18405080746186042
Current ratio: 2.961305503507778
Quick ratio: 1.6266503987101832
Effective tax rate (%): 39.68305304010349
Interest coverage ratio: 7.192631578947369
COGS to revenue (%): 34.455890250451596
SG&A to revenue (%): 5.001220524337255
Free cash flow (dilution-adjusted): 4081250
Buyback yield (%): 0
Retained earnings: 52223958.333333336
Inventory turnover: 1.152110744719057
Receivables turnover: 6.1337365993891115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.861362018236874
FCF margin (%): 3.825611482692965
Revenue growth (%): -18.621805738017542
Rule of 40 score: -14.796194255324577
Financial ratios for M7U.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 51992708.333333336
Buffett classification: The Gruesome
Stock price: 18.333333333333336
Shares outstanding: 6568820
Book value: 107267708.33333334
P/B ratio: 1.1226898433630812
Market cap (USD): 120428366.66666669
Debt to equity: 0.18405080746186042
Current ratio: 2.961305503507778
Quick ratio: 1.6266503987101832
Buyback yield (%): 0
Retained earnings: 52223958.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for M7U.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.294117647058826
Shares outstanding: 6568820
Market cap (USD): 120170765.88235296
Quick ratio: -1.663437629506838
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAGNUM.NS — annual report dated 2022-03-31
Total revenue: 42201635.2367137
Gross profit: 10333245.417380985
Operating income: 1122959.250956086
Net income: 678847.4218646974
Capital expenditures: 2688751.1538968747
Operating cash flow: 3026664.9083476197
Depreciation & amortization: 1988250.0329684822
Net tangible assets: -6757154.160622445
Owner earnings: -21653.699063695036
Capex to operating income (%): 239.43443643281586
Buffett classification: The Gruesome
Stock price: 0.1389951206646446
P/E ratio: 14.007329121355168
Shares outstanding: 68411317
Book value: -6748292.232625611
Market cap (USD): 9508839.261242252
Debt to equity: -5.814426945828114
Current ratio: 0.7210037231326439
Quick ratio: 0.48790530764180595
Effective tax rate (%): -9.974790634079644
Interest coverage ratio: 3.5408540895671337
COGS to revenue (%): 75.51458525381624
SG&A to revenue (%): 2.4373232504726343
Free cash flow (dilution-adjusted): 337913.7544507451
Buyback yield (%): 0
Retained earnings: -18849070.288803905
Inventory turnover: 7.342304431973895
Receivables turnover: 5.7622049484216795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.90046170942404
FCF margin (%): 0.8007124666031281
Rule of 40 score: 0.8007124666031281
Financial ratios for MAGNUM.NS — annual report dated 2023-03-31
Total revenue: 55219062.11936663
Gross profit: 14007283.800243607
Operating income: 3106930.5724725947
Net income: 8631059.683313033
Capital expenditures: 574445.7978075518
Operating cash flow: 12073532.27771011
Depreciation & amortization: 2040401.9488428747
Net tangible assets: 71115736.90621194
Owner earnings: 10097015.834348354
Return on net tangible assets (%): 14.198004933372745
Capex to operating income (%): 18.489173942190458
Buffett classification: The Great
Stock price: 0.3380024360535932
P/E ratio: 2.679067536091786
Shares outstanding: 68411317
Book value: 71125371.49817297
P/B ratio: 0.3251046892630792
Market cap (USD): 23123191.799634594
Debt to equity: 0.3225131447737804
Current ratio: 0.8301618636988533
Quick ratio: 0.40424569118908565
Effective tax rate (%): -2.1839602575472448
Interest coverage ratio: 6.6233641462401325
COGS to revenue (%): 74.6332457259702
SG&A to revenue (%): 1.799432445458626
Free cash flow (dilution-adjusted): 11499086.479902558
Buyback yield (%): 2.3703996542291703
Retained earnings: -8778501.827040195
Inventory turnover: 5.951625159631168
Receivables turnover: 11.361633714854255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.805392251640756
FCF margin (%): 20.824487121938198
Revenue growth (%): 30.845787869680226
Rule of 40 score: 51.67027499161843
Financial ratios for MAGNUM.NS — annual report dated 2024-03-31
Total revenue: 55262717.3522005
Gross profit: 14781796.378462646
Operating income: 1029883.6790982132
Net income: 2962309.6294519724
Capital expenditures: 6680956.949274493
Operating cash flow: 2501031.2987168725
Depreciation & amortization: 5323132.270056361
Net tangible assets: 81650521.64528121
Owner earnings: 1604484.9502338404
Return on net tangible assets (%): 1.9650639308886368
Capex to operating income (%): 648.709857711744
Buffett classification: The Gruesome
Stock price: 0.5296305182341651
P/E ratio: 12.231240419825662
Shares outstanding: 68411317
Book value: 81658160.45089337
P/B ratio: 0.4437121908664714
Market cap (USD): 36232721.27579175
Debt to equity: 0.2916570354773365
Current ratio: 2.5124091847762124
Quick ratio: 1.9522972640409164
Effective tax rate (%): -131.34107510769806
Interest coverage ratio: 1.762766830870279
COGS to revenue (%): 68.9158915171087
SG&A to revenue (%): 2.3567613453642275
Free cash flow (dilution-adjusted): -4179937.642403166
Buyback yield (%): 2.556722309931651
Retained earnings: -3327437.3426070274
Inventory turnover: 7.583674005444387
Receivables turnover: 7.100049302067605
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.809690491043974
FCF margin (%): -7.563756982421939
Revenue growth (%): 0.07905826567553895
Rule of 40 score: -7.4846987167464
Financial ratios for MAGNUM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5556617295747731
Shares outstanding: 68411317
Market cap (USD): 38013550.72670808
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAGNUM.NS — quarterly report dated 2024-12-31
Total revenue: 12024478.377433266
Gross profit: 4822310.292574892
Operating income: 1008474.1811399929
Net income: 975556.5916773516
Capital expenditures: 0
Depreciation & amortization: 1359004.5459843804
Net tangible assets: 80430889.38104674
Owner earnings: 2334561.137661732
Return on net tangible assets (%): 2.9025678512661863
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.4584450402144772
P/E ratio: 8.037162897763254
Shares outstanding: 68411317
Book value: 80438314.48886815
P/B ratio: 0.3898991316822116
Market cap (USD): 31362828.973190345
Debt to equity: 0.28016391715572814
Current ratio: 1.97641507431899
Quick ratio: 1.231250477492084
Effective tax rate (%): -641.6304829419583
Interest coverage ratio: 1.1007391951551546
COGS to revenue (%): 59.89588786133891
Buyback yield (%): 0
Inventory turnover: 0.879835274919154
Receivables turnover: 1.8761764978693454
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8225057233723791
Rule of 40 score: 0
Financial ratios for MAGNUM.NS — quarterly report dated 2025-03-31
Total revenue: 13899298.573766658
Gross profit: 5477016.600420855
Operating income: 1263373.8601823708
Net income: 630617.2550853401
Capital expenditures: 0
Depreciation & amortization: 1357587.0937573065
Net tangible assets: 81285211.59691373
Owner earnings: 1988204.3488426465
Return on net tangible assets (%): 2.4459607224767757
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2786789590383942
P/E ratio: 7.557989594427448
Shares outstanding: 68411317
Book value: 81292658.40542436
P/B ratio: 0.2345204964626114
Market cap (USD): 19064794.6080056
Debt to equity: 0.2993065348399301
Current ratio: 2.3251803020329325
Quick ratio: 1.5579969537244802
Effective tax rate (%): -136.45289966247316
Interest coverage ratio: 1.3275474479454579
COGS to revenue (%): 60.595014407719106
Buyback yield (%): 0
Inventory turnover: 1.1280277575100912
Receivables turnover: 2.0178029557319066
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.014092611431342
Revenue growth (%): 15.591696683092119
Rule of 40 score: 15.591696683092119
Financial ratios for MAGNUM.NS — annual report dated 2025-03-31
Total revenue: 46264975.45008183
Gross profit: 19051133.972410567
Operating income: 3638578.4428337617
Net income: 1110100.5377601122
Capital expenditures: 8295440.729483282
Operating cash flow: 4671007.715688567
Depreciation & amortization: 5354465.747018938
Net tangible assets: 81285211.59691373
Owner earnings: -1830874.4447042318
Return on net tangible assets (%): -2.25240779809171
Capex to operating income (%): 227.98576036807137
Buffett classification: The Gruesome
Stock price: 0.2786789590383942
P/E ratio: 17.17393511624928
Shares outstanding: 68411317
Book value: 81292658.40542436
P/B ratio: 0.2345204964626114
Market cap (USD): 19064794.6080056
Debt to equity: 0.2993065348399301
Current ratio: 2.3251803020329325
Quick ratio: 1.5579969537244802
Interest coverage ratio: 0.9707354651978779
COGS to revenue (%): 58.821692247592296
Free cash flow (dilution-adjusted): -7020528.40776245
Buyback yield (%): 4.614292569470405
Inventory turnover: 3.644851677068426
Receivables turnover: 6.7164255602245655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.920636267128747
FCF margin (%): -15.174607442161806
Revenue growth (%): -16.281757997483613
Rule of 40 score: -31.456365439645417
Financial ratios for MAGNUM.NS — quarterly report dated 2025-06-30
Total revenue: 13546864.029955536
Gross profit: 3448654.3412122633
Operating income: -846852.3285747719
Net income: -2124842.0313597005
Capital expenditures: 0
Depreciation & amortization: 1632249.0053826352
Net tangible assets: 79236461.50245729
Owner earnings: -492593.0259770653
Return on net tangible assets (%): -0.6216746894506249
Buffett classification: The Gruesome
Stock price: 0.3135970044465247
Shares outstanding: 68411317
Book value: 79243915.28200328
P/B ratio: 0.27072847177092774
Market cap (USD): 21453584.08144161
Debt to equity: 0.3239963172890286
Current ratio: 2.1667360065844736
Quick ratio: 1.476468963340042
Interest coverage ratio: -0.8090143868003622
COGS to revenue (%): 74.5427847095356
Buyback yield (%): 0
Inventory turnover: 1.4096079526707632
Receivables turnover: 1.9311987055448057
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6822108147551419
Revenue growth (%): -2.5356282688703584
Rule of 40 score: -2.5356282688703584
Financial ratios for MAGNUM.NS — quarterly report dated 2025-09-30
Total revenue: 13371138.669673055
Gross profit: 4774306.651634724
Operating income: 957779.0304396843
Net income: 135219.84216459977
Capital expenditures: 0
Depreciation & amortization: 1225118.376550169
Net tangible assets: 76477350.62006764
Owner earnings: 1360338.2187147688
Return on net tangible assets (%): 1.778746527809001
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2798196166854566
P/E ratio: 35.39204785601134
Shares outstanding: 68411317
Book value: 76484532.1307779
P/B ratio: 0.2502836582324343
Market cap (USD): 19142828.499887258
Debt to equity: 0.39355350051251603
Current ratio: 2.455076594304998
Quick ratio: 1.7367764011597282
Interest coverage ratio: 0.8537075557967301
COGS to revenue (%): 64.2939410802516
Buyback yield (%): 0
Inventory turnover: 1.1365894520950184
Receivables turnover: 1.7997268588770865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7685973322602253
Revenue growth (%): -1.2971663397071647
Rule of 40 score: -1.2971663397071647
Financial ratios for MAGNUM.NS — quarterly report dated 2025-12-31
Total revenue: 11349526.567895735
Gross profit: 4824774.423526791
Operating income: 872808.2878467194
Net income: 29074.300991422526
Capital expenditures: 0
Depreciation & amortization: 1215740.2250194943
Net tangible assets: 76173565.77921355
Owner earnings: 1244814.5260109168
Return on net tangible assets (%): 1.6341817706407087
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2576584605101927
P/E ratio: 151.5664523189655
Shares outstanding: 68411317
Book value: 76180661.6909881
P/B ratio: 0.23138095979258155
Market cap (USD): 17626754.619694773
Debt to equity: 0.3902921854880242
Current ratio: 2.5918755391687642
Quick ratio: 1.4719632242587535
Interest coverage ratio: 0.7862956235511355
COGS to revenue (%): 57.48920102822112
Buyback yield (%): 0
Inventory turnover: 0.6180634622831944
Receivables turnover: 2.2380731667669815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6973679326990813
Revenue growth (%): -15.119221718659748
Rule of 40 score: -15.119221718659748
Financial ratios for MFD.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7681159420289856
Shares outstanding: 75424609
Market cap (USD): 57934844.594202906
Buyback yield (%): 0.7752149304329562
Capitalized R&D asset: 0
Rule of 40 score: 0